Table 5.

Primary and secondary outcomes of trial by Lau et al. [113]

Outcome	TC-325 (n = 111)	Standard treament (n = 113)	Odds ratio (95% CI)
Control of bleeding within 30 days	90.1%	81.4%	8.7 (0.95)∗
Failed immediate hemostasis	2.7%	9.7%	0.26 (0.07-0.95)
30-day rebleeding	8.1%	8.5%	0.91 (0.37-2.22)
Need for further treatment of bleeding	9.0%	10.6%	0.83 (0.34-2.02)
30-day mortality	12.6%	12.4%	1.02 (0.46-2.25)

CI, confidence interval.

^∗ Between-group difference (1-sided 95% CI)